113 related articles for article (PubMed ID: 7658704)
1. Expression on leukemic cells and serum circulating levels of intercellular adhesion molecule-1 (ICAM-1) in B-cell chronic lymphocytic leukemia: implications for prognosis.
Molica S; Dattilo A; Mannella A; Levato D; Levato L
Leuk Res; 1995 Aug; 19(8):573-80. PubMed ID: 7658704
[TBL] [Abstract][Full Text] [Related]
2. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
[TBL] [Abstract][Full Text] [Related]
3. Clinico-prognostic relevance of quantitative immunophenotyping in B-cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins.
Molica S; Levato D; Dattilo A; Mannella A
Eur J Haematol; 1998 Jan; 60(1):47-52. PubMed ID: 9451427
[TBL] [Abstract][Full Text] [Related]
4. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
[TBL] [Abstract][Full Text] [Related]
6. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia.
Kamper EF; Papaphilis AD; Angelopoulou MK; Kopeikina LT; Siakantaris MP; Pangalis GA; Stavridis JC
Clin Biochem; 1999 Nov; 32(8):639-45. PubMed ID: 10638947
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia.
Christiansen I; Sundström C; Tötterman TH
Br J Haematol; 1998 Dec; 103(4):1129-37. PubMed ID: 9886331
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of bone-marrow pattern and immunophenotypic score in B-chronic lymphocytic leukemia at diagnosis.
Jahic A; Iljazovic E; Arnautovic-Custovic A; Halilbasic A; Simendic V; Zabic A
Med Arh; 2011; 65(3):132-6. PubMed ID: 21776871
[TBL] [Abstract][Full Text] [Related]
13. Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters.
Jurisic V; Colovic N; Kraguljac N; Atkinson HD; Colovic M
Med Oncol; 2008; 25(3):315-22. PubMed ID: 18183502
[TBL] [Abstract][Full Text] [Related]
14. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
[TBL] [Abstract][Full Text] [Related]
15. Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: malignant cell phenotypes define distinct disease subsets.
De Rossi G; Zarcone D; Mauro F; Cerruti G; Tenca C; Puccetti A; Mandelli F; Grossi CE
Blood; 1993 May; 81(10):2679-87. PubMed ID: 7683926
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
[TBL] [Abstract][Full Text] [Related]
17. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G
Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
[TBL] [Abstract][Full Text] [Related]
19. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia.
Kimby E; Rincón J; Patarroyo M; Mellstedt H
Leuk Lymphoma; 1994 Apr; 13(3-4):297-306. PubMed ID: 7519509
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
